Your browser doesn't support javascript.

Biblioteca Virtual em Saúde

Brasil

Home > Pesquisa > ()
Imprimir Exportar

Formato de exportação:

Exportar

Email
Adicionar mais destinatários
| |

Ensuring quality in cervical screening programmes based on molecular human papillomavirus testing.

Cuschieri, Kate; Schuurman, Rob; Coughlan, Suzie.
Cytopathology; 30(3): 273-280, 2019 May.
Artigo em Inglês | MEDLINE | ID: mdl-30657615
The increased use of human papillomavirus testing within cervical screening programmes necessarily brings about changes to the laboratory services required to support them. A crucial element of such services is to demonstrate initial and ongoing quality of the test (and associated processes). In this review, we outline some of the quality considerations and challenges with an emphasis on the laboratory including assay and platform validation, internal quality control selection and strengths and weaknesses of external quality assurance schemes. The influence and role of key external entities, including regulatory agencies, guideline groups, programme commissioners and commercial providers, are also discussed.
Selo DaSilva